LifeMD (NASDAQ:LFMD) reported second-quarter revenue of $47.3 million, within its prior guidance range, while posting an ...
Nyxoah (NASDAQ:NYXH) reported second-quarter worldwide net revenue of €7.7 million, up 21% sequentially from the first ...
Braveheart is one of five biotechnology firms that made plans to price an IPO this week, bringing in total what could ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results